Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report
Background: Uterine serous carcinoma (USC) is a biologically aggressive variant of uterine cancer. Effective treatment options for recurrent, chemotherapy-resistant USC are extremely limited. Case: We describe a 74-year-old woman with recurrent and widespread treatment-resistant disease, who experie...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Elsevier
2018-08-01
|
| Sraith: | Gynecologic Oncology Reports |
| Rochtain ar líne: | http://www.sciencedirect.com/science/article/pii/S2352578918300456 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|